Ulthera System Transducer UT-1 Rev NRecalls & reported problems
Ulthera, Inc. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00840763100865), received between Jun 17, 2022 and Jun 2, 2023 — classified as 2 injuries.
The most frequently reported specific device problem is “Computer Operating System Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Computer Operating System Problem1
- Dent in Material1
- Image Display Error/Artifact1
- Noise, Audible1
Patient problems
- Bruise/Contusion1
- Erythema1
- Partial thickness (Second Degree) Burn1
- Scar Tissue1
- Wheal(s)1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJun 2, 2023Image Display Error/Artifact; Dent in Material; Computer Operating System Problem; Noise, Audible; Image Display Error/Artifact; Dent in Material; Computer Operating System Problem; Noise, Audible
ON (B)(6) 2023, A KOREAN AFFILIATE ALLEGED AN ADVERSE EVENT OCCURRED FOLLOWING ULTHERAPY TREATMENT. THIS SPONTANEOUS REPORT RECEIVED FROM A KOREAN PHYSICIAN IS CONCERNING A PATIENT OF UNKNOWN AGE AND GENDER. ACCORDING TO THE REPORT: "IT FEELS LIKE THE SHOT DIDN'T GO OUT AS IT SHOULD HAVE, AND THERE'S A BURN ON THE LEFT SIDE." PER THE REPORTING EMAIL, THE BURN IS ON THE LEFT SIDE OF THE PATIENT'S FACE, AND THE TREATMENT WAS PERFORMED ON (B)(6) 2023. ON 06-MAR-2023, ADDITIONAL INFORMATION WAS RECEIVED STATING A CODE G (NON-SPECIFIC HARDWARE ISSUE) OCCURRED DURING THE TREATMENT, AND THE PHYSICIAN ESTIMATED THE BURN TO BE SECOND-DEGREE AND RECOMMENDED THAT THE PATIENT BE TREATED AT A BURN HOSPITAL. ON 22-MAR-2023, THE KOREAN AFFILIATE REPORTED THAT THE PATIENT'S SYMPTOMS WERE "RESOLVING." THE FINAL OUTCOME OF THE EVENT WAS NOT REPORTED. A REVIEW OF THE SUPPORT LOG REVEALED 372 TOTAL LINES WERE DELIVERED DURING THIS TREATMENT. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THIS REPORT WAS INITIALLY SUBMITTED UNDER AN INCORRECT MANUFACTURER FEI NUMBER: 3006560326-2023-00014.
Patient problems: Partial thickness (Second Degree) Burn
MAUDE report 17052202 ↗InjuryJun 17, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A MERZ (B)(4) AFFILIATE REPORTED VIA EMAIL ON (B)(6) 2022 REGARDING AN ALLEGED ADVERSE EVENT FOLLOWING AN ULTHERAPY TREATMENT. ACCORDING TO THE REPORT, "39-YEAR-OLD PATIENT WITH NO MEDICAL OR SURGICAL HISTORY OF INTEREST. SHE COMES TO THE CONSULTATION FOR ULTHERAPY TREATMENT OF THE LOWER THIRD, SHE IS AWARE OF THE PROCESS, WHICH HAS ALREADY BEEN CARRIED OUT ON ANOTHER OCCASION IN ANOTHER COUNTRY. ON (B)(6) 2022 ULTHERAPY TREATMENT WAS PERFORMED ON THE LOWER 2/3 OF THE FACE AND NECK, 400 TOTAL LINES COMBINING TRANSDUCER 4-4.5 AT 1.20J AND 7-3.0 AT 0.30J. WELL TOLERATED TREATMENT WITH NO INCIDENTS DURING IT. AT THE END OF THE TREATMENT, THE PATIENT PRESENTED MODERATE ERYTHEMA AND DISCRETE EDEMATOUS LINES ON BOTH CHEEKS, HOME DIPROGENTA AND SUN PROTECTION WERE PRESCRIBED. ON FEBRUARY 28TH, THE PATIENT SENDS PHOTOS SHOWING INFLAMMATION, HEMATOMA AND LINEAR LESIONS MAINLY ON BOTH CHEEKS. DUE TO PERSONAL PROBLEMS, THE PATIENT DID NOT GO TO CONTROL UNTIL (B)(6) 2022, AN INFLAMMATORY PROCESS IS OBSERVED ABOVE THE USUAL, ERYTHEMA ON BOTH CHEEKS, HEMATOMA AND LINEAR LESIONS WITH LOSS OF CONTINUITY OF THE SKIN. SINCE THEN, PERIODIC CHECK-UPS HAVE BEEN CARRIED OUT ON THE PATIENT AND DIFFERENT
Patient problems: Bruise/Contusion; Erythema; Scar Tissue; Wheal(s)
MAUDE report 14738772 ↗
Other Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption devices
- Sofwave FG00001Sofwave Medical Ltd · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption12 reports
- Ulthera System Control Unit UC-1 Rev. DUlthera, Inc. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption7 reports
- Ulthera System Control Unit UC-1 Rev RUlthera, Inc. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption6 reports
- Ulthera System Control Unit PRIME UC-1 Control Unit (PRIME) Rev. AUlthera, Inc. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption4 reports
- Ulthera System Control Unit UC-1 Rev. FUlthera, Inc. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption2 reports
- Ulthera System Control Unit UC-1 Rev. LUlthera, Inc. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption2 reports
- Ulthera System Control Unit UC-1 Rev. EUlthera, Inc. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption1 report
- Ulthera System Control Unit UC-1 Rev. BUlthera, Inc. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page